[go: up one dir, main page]

DE60139783D1 - Gen und pflanzenextrakte, wirksam zur behandlung und prävention von chlamydieninfektionen - Google Patents

Gen und pflanzenextrakte, wirksam zur behandlung und prävention von chlamydieninfektionen

Info

Publication number
DE60139783D1
DE60139783D1 DE60139783T DE60139783T DE60139783D1 DE 60139783 D1 DE60139783 D1 DE 60139783D1 DE 60139783 T DE60139783 T DE 60139783T DE 60139783 T DE60139783 T DE 60139783T DE 60139783 D1 DE60139783 D1 DE 60139783D1
Authority
DE
Germany
Prior art keywords
chlamydiene
infections
gene
prevention
effective
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60139783T
Other languages
English (en)
Inventor
Heikki Vuorela
Pia Vuorela
Raimo Hiltunen
Maija Leinonen
Pekka Saikku
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CONTROL OX Oy
Original Assignee
CONTROL OX Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FI20001832A external-priority patent/FI113942B/fi
Application filed by CONTROL OX Oy filed Critical CONTROL OX Oy
Application granted granted Critical
Publication of DE60139783D1 publication Critical patent/DE60139783D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Emergency Medicine (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE60139783T 2000-08-17 2001-08-16 Gen und pflanzenextrakte, wirksam zur behandlung und prävention von chlamydieninfektionen Expired - Lifetime DE60139783D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22573500P 2000-08-17 2000-08-17
FI20001832A FI113942B (fi) 2000-08-18 2000-08-18 Kasviperäisten fenolisten yhdisteiden käyttö valmistettaessa klamydiainfektion hoidossa ja ennaltaehkäisyssä käyttökelpoista farmaseuttista valmistetta, terveyteen myönteisesti vaikuttavaa ravintoainekoostumusta tai koostumusta lisättäväksi tällaisiin elintarvikkeisiin
PCT/FI2001/000726 WO2002014464A2 (en) 2000-08-17 2001-08-16 Plant-derived and synthetic phenolic compounds and plant extracts, effective in the treatment and prevention of chlamydial infections

Publications (1)

Publication Number Publication Date
DE60139783D1 true DE60139783D1 (de) 2009-10-15

Family

ID=26161043

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60139783T Expired - Lifetime DE60139783D1 (de) 2000-08-17 2001-08-16 Gen und pflanzenextrakte, wirksam zur behandlung und prävention von chlamydieninfektionen

Country Status (21)

Country Link
EP (1) EP1309333B1 (de)
JP (1) JP2004506656A (de)
KR (1) KR100851357B1 (de)
CN (1) CN100500141C (de)
AR (1) AR034141A1 (de)
AT (1) ATE441424T1 (de)
AU (2) AU2001282201B2 (de)
BR (1) BR0113463A (de)
CA (1) CA2419716A1 (de)
CZ (1) CZ2003449A3 (de)
DE (1) DE60139783D1 (de)
EE (1) EE200300064A (de)
ES (1) ES2330306T3 (de)
HU (1) HUP0300732A3 (de)
MX (1) MXPA03001435A (de)
NO (1) NO20030728L (de)
NZ (1) NZ524128A (de)
PT (1) PT1309333E (de)
SG (1) SG90259A1 (de)
TW (1) TWI282275B (de)
WO (1) WO2002014464A2 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4571829B2 (ja) * 2003-07-15 2010-10-27 林原 健 抗クラミジア組成物
US8455541B2 (en) 2005-05-30 2013-06-04 Korea Research Institute Of Bioscience And Biotechnology Pharmaceutical composition comprising an extract of pseudolysimachion longifolium and the catalpol derivatives isolated therefrom having antiinflammatory, antiallergic and antiasthmatic activity
CA2610211C (en) * 2005-05-30 2012-02-21 Hyeong Kyu Lee Pharmaceutical composition comprising an extract of pseudolysimachion longifolium and the catalpol derivatives isolated therefrom having antiinflammatory, antiallergic and antiasthmatic activity
FR2890311B1 (fr) * 2005-09-07 2009-10-30 Oreal Utilisation cosmetique d'un extrait vegetal du genre rosa comme agent empechant ou reduisant l'adhesion des microorganismes sur la surface de la peau et/ou des muqueuses
WO2009003838A2 (en) * 2007-07-05 2009-01-08 Unilever N.V. Composition comprising polyphenol
WO2009003832A2 (en) * 2007-07-05 2009-01-08 Unilever N.V. Composition comprising polyphenol
DK2585088T3 (da) 2010-06-25 2014-08-25 Horphag Res Ip Pre Ltd Sammensætning til forbedring af seksuel sundhed
CN102935131B (zh) * 2011-08-15 2015-01-07 天津药物研究院 枳实总黄酮提取物在制备用于治疗哮喘药物中的应用
KR101419706B1 (ko) * 2012-12-28 2014-07-15 한국식품연구원 생체내에서의 항염증 효능이 증가된 염증치료용 루테올린 혼합 조성물을 제조하는 방법 및 항염증이 증가된 염증치료용 루테올린 혼합 조성물
KR102105532B1 (ko) * 2013-10-17 2020-04-29 (주)아모레퍼시픽 만능 줄기세포의 유도 방법 및 상기 방법에 의해 제조된 만능줄기세포
US20170340691A1 (en) * 2014-12-23 2017-11-30 Neem Biotech Limited An Antimicrobial Composition
US10039727B2 (en) 2015-04-21 2018-08-07 Commissariat A L'energie Atomique Et Aux Energies Alternatives Adamantane or pinene derivatives for use in the treatment of chlamydiales infections
IT201700089680A1 (it) * 2017-08-03 2019-02-03 Giuliani Spa Composizione sinergica come promoter di autofagia/a synergistic composition as a promoter of autophagy
KR102166099B1 (ko) 2018-08-01 2020-10-15 건국대학교 산학협력단 비아칸젤리신을 포함하는 폐 또는 뇌의 생체분포도 증진을 위한 약제학적 제형
KR102313068B1 (ko) 2018-08-01 2021-10-14 건국대학교 산학협력단 비아칸젤리신을 포함하는 폐 또는 뇌의 생체분포도 증진을 위한 약제학적 제형
CN111675220B (zh) * 2020-05-08 2023-06-27 江西江氨科技有限公司 碳酸酯生产尾气中含co2提取精制系统
CN113024575B (zh) * 2021-03-23 2022-04-22 上海市奉贤区中心医院 一种黄烷-3-醇并苯丙素杂合物、其制备方法及其应用
CN116078128B (zh) * 2022-11-30 2024-12-06 北京华能长江环保科技研究院有限公司 阴燃烟气处理方法和系统以及固废处理系统
CN119792331B (zh) * 2025-03-17 2025-07-04 天津医科大学总医院 一种小分子化合物k3g在治疗衣原体感染中的应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3206725A1 (de) * 1981-05-13 1982-12-02 Merck Patent Gmbh, 6100 Darmstadt Schwer loesliche salze von aminoglykosidantibiotika
KR920003577B1 (ko) * 1987-12-10 1992-05-04 주식회사 쓰무라 항 레트로바이러스제
US4891221A (en) * 1988-11-23 1990-01-02 Edward Shanborm Whole blood antiviral process and composition
DE4200555C2 (de) * 1991-01-23 2003-02-27 Viatris Gmbh Herstellung eines Kamillenextraktes mit antimikrobiellen Eigenschaften
CN1106682A (zh) * 1994-02-05 1995-08-16 蔡惠明 一种用于治疗妇女阴道炎及常见性病预防的中药制剂
US5474774A (en) * 1994-03-25 1995-12-12 Jlb, Inc. Adhesion inhibiting composition
CN1151846A (zh) * 1995-12-15 1997-06-18 四川保宁制药厂 银杏保健饮料
ES2217563T3 (es) * 1997-07-11 2004-11-01 Toray Industries, Inc. Compuestos medicinales estables que contienen derivados de 4,5-epoximorfinado.
PL339144A1 (en) * 1997-09-09 2000-12-04 Rutgers Proantocyanidin containing plant extract efficiently inhibiting adherence of bacteria with p-type fimbriae to surfaces
EP1043318A4 (de) * 1997-11-19 2001-02-07 Tets Viktor Veniaminovich Salze der 5,5'-arylidenbisbarbitur- und 5,5'-arylidenbis(2-thiobarbitur)säuren und 5,5'-arylidenbis(2-thiobarbitur)säure mit antibakteriellen, antichlamydialen, antiviralen und immunmodulierenden eigenschaften
KR100417703B1 (ko) * 1998-04-21 2004-02-11 미쓰이 노린 가부시키가이샤 항클라미디아제
CN1226405A (zh) * 1998-12-17 1999-08-25 童忠良 银杏沙棘饮料

Also Published As

Publication number Publication date
MXPA03001435A (es) 2004-12-13
PT1309333E (pt) 2009-09-29
SG90259A1 (en) 2002-07-23
WO2002014464A2 (en) 2002-02-21
WO2002014464B1 (en) 2002-11-21
TWI282275B (en) 2007-06-11
EE200300064A (et) 2004-12-15
NZ524128A (en) 2006-01-27
EP1309333B1 (de) 2009-09-02
JP2004506656A (ja) 2004-03-04
KR100851357B1 (ko) 2008-08-08
CN1454093A (zh) 2003-11-05
BR0113463A (pt) 2003-07-15
AU8220101A (en) 2002-02-25
AU2001282201B2 (en) 2006-05-11
NO20030728L (no) 2003-04-14
WO2002014464A3 (en) 2002-05-10
ATE441424T1 (de) 2009-09-15
ES2330306T3 (es) 2009-12-09
CA2419716A1 (en) 2002-02-21
EP1309333A2 (de) 2003-05-14
AR034141A1 (es) 2004-02-04
NO20030728D0 (no) 2003-02-14
CN100500141C (zh) 2009-06-17
HUP0300732A2 (hu) 2003-09-29
CZ2003449A3 (cs) 2003-06-18
KR20030051623A (ko) 2003-06-25
HUP0300732A3 (en) 2005-09-28

Similar Documents

Publication Publication Date Title
DE60139783D1 (de) Gen und pflanzenextrakte, wirksam zur behandlung und prävention von chlamydieninfektionen
DE60023128D1 (de) Pyrazolecarboxamide zur behandlung von fettleibigkeit und anderen erkrankungen
DE60103137D1 (de) Impstoff zur behandlung von atherosclerosis
DE60108080D1 (de) Aminopyrazolderivate zur behandlung von übergewicht und anderen gesundheitsstörungen
DE60124302D1 (de) Thiazolderivate zur behandlung von ppar-lierte krankheiten
DE60019556D1 (de) 2-amino-benzoxazinonderivate zur behandlung von fettleibigkeit
DE69737793D1 (de) Benzimidazol-2-carbamat zur behandlung viraler infektionen und von krebs
DE69934877D1 (de) Biochanin-angereicherter extrakt zur behandlung von estrogenabhängigen erkrankungen
DE60035378D1 (de) Gerät zur Behandlung von Bandscheiben
DE60019555D1 (de) 2-oxy-benzoxazinonderivate zur behandlung von fettleibigkeit
ATE451921T1 (de) Phenylindole zur behandlung von hiv
ATE417602T1 (de) Mittel zur behandlung von erkrankungen der speiseröhre
DE50212701D1 (de) Bestrahlungsanordnung zur behandlung von akne und aknenarben
EP1085892A4 (de) Impfstrategie zur vorbeugung und behandlung von krebs
DE60136477D1 (de) Retinoide zur behandlung von emphysem
DE60132851D1 (de) Arzneimittel zur Vorbeugung, Erleichterung oder Behandlung von Hypertension
DE50013843D1 (de) Arzneimittel zur behandlung von darmerkrankungen
DE50114605D1 (de) No-thien-2-yl-essigsaure-derivate und ihre verwendung zur behandlung von migraine bzw. schmerz
DE60016047D1 (de) Dihydrobenzopyrane, dihydrobenzothiopyrane und tetrahydrochinoline zur behandlung cox-2-abhängiger krankheiten
ATE431142T1 (de) Arzneimittel zur behandlung und vermeidung neurogener schmerzen
ATE273276T1 (de) Cyclobutendion-derivate zur behandlung von artherosclerose
DE50105735D1 (de) Chlorzoxazon zur behandlung von psoriasis
ATE443060T1 (de) Benzoägüchinolinderivate zur behandlung von glaucom und kurzsichtigkeit
ATE347888T1 (de) Verwendung von aivlosin zur behandlung und prevention der lawsonia-infektionen in schweinen.
DE60006412D1 (de) Oxazinochinolone zur behandlung von viralen infektionen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition